(EP3270910) Astaxanthin compositions (iv) 机翻标题: 暂无翻译,请尝试点击翻译按钮。

源语言标题
(EP3270910) Astaxanthin compositions (iv)
公开号/公开日
EP3270910EP3270910 / 2018-01-242019-05-22
申请号/申请日
EP16710443 / 2016-03-18
发明人
FELDTHUSEN JENSEN JESPERRAUSCH TAMARA ALEXANDRASCHOLTEN CLAUDIASCHAEFER BERND;
申请人
BASF;
主分类号
IPC分类号
A23K-020/105 A23K-020/179 A23K-050/80 A23L-033/00 A23L-033/105 A61K-031/122 A61K-031/202 A61K-031/23 C07C-403/24
摘要
(EP3270910) The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particularly at least 70 wt.%, and especially at least 80 wt.% or at least 90 wt.%, relative to the total weight of astaxanthin and astaxanthin derivatives in the composition, a monoester of the astaxanthin having C18-1 - fatty acid, have a particularly high bioavailability. They are therefore particularly suitable for use in foods, food supplements or animal feed and for therapeutic use as a medicament and as an ingredient for medical preparations or pharmaceutical agents.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
(EP3270910) BASF IP Association ; BASF SE ([DE]) Reg. Nb: 101647202
代理机构
;
优先权号
2015EP-0159833 2016WO-EP55922
主权利要求
(EP3270910) 1. The use of astaxanthin compositions in foodstuffs, food supplements or feedstuffs, where the astaxanthin composition comprises at least 90% by weight, based on the total weight of astaxanthin and astaxanthin derivatives in the composition, of monoesters of astaxanthin with a C18-1 fatty acid. 2. The use according to claim 1, wherein less than 60% by weight of the unsaturated fatty acids which are present in the astaxanthin monoester are present as trans-fatty acids. 3. The use according to any of the preceding claims, wherein at least 40% by weight of the astaxanthin monoester are present in the form of monoesters of all-trans astaxanthin. 4. The use according to any of the preceding claims, wherein at least 90% by weight of the astaxanthin monoester are present in the form of monoesters of an astaxanthin which either has the (S) or the (R) configuration in the asymmetric centers in positions 3 and 3', respectively. 5. A composition in the form of a food additive, feed additive or food supplement, comprising at least 90% by weight, based on the total weight of astaxanthin and astaxanthin derivatives in the composition, of monoesters of astaxanthin with a C18-1 fatty acid and an adjuvant which is suitable for foodstuffs, feedstuffs or food supplements. 6. The composition according to claim 5, selected among solutions and suspensions of the astaxanthin composition and an oil or fat which is suitable for foodstuffs or feedstuffs. 7. The composition according to claim 5 in the form of a powder, comprising an astaxanthin composition and a protective colloid. 8. The composition according to claim 5 in the form of a food supplement for oral administration. 9. A process for the preparation of a foodstuff or feedstuff, comprising the addition of an astaxanthin composition according to the definition in any of claims 1 to 4 to a conventional foodstuff or feedstuff. 10. The astaxanthin composition according to the definition in any of claims 1 to 4 for the therapeutic use as medicament and as constituent for a medicinal preparation. 11. The astaxanthin composition according to claim 10 for the treatment or prevention of joint diseases, eye diseases, skin diseases, heart diseases, diseases of the blood vessels, inflammatory diseases, tumor diseases, bacterial infections, type-2 diabetes and associated sequelae, degenerative nerve disorders and for strengthening the immune system.
法律状态
GRANTED
专利类型码
A1B1
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部